India

Cipla

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

INDIA India

Post An Enquiry

Virtual Booth

BIO Digital 2021

Participation Not Confirmed

Update your events

Cipla Receives Final Approvl for Generic Version of GlaxoSmithKline’s IMITREX®

Lead Product(s): Sumatriptan

Therapeutic Area: Neurology Product Name: Undisclosed

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 02, 2021

Details:

Cipla’s Sumatriptan Nasal Spray USP, 20 mg is an AB-rated generic therapeutic equivalent version of GlaxoSmithKline’s Imitrex® Nasal Spray.

Natco Pharma Limited

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

INDIA India

Post An Enquiry

Virtual Booth

BIO Digital 2021

Participation Not Confirmed

Update your events

Natco Pharma Launches Epilepsy Treatment Drug Brivaracetam in India

Lead Product(s): Brivaracetam

Therapeutic Area: Neurology Product Name: Brecita

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable February 26, 2021

Details:

Natco Pharma has launched Brivaracetam tablets under brand BRECITA in India. Brivaracetam, indicated towards the treatment of epilepsy, is developed by UCB Pharma and currently marketed in India by Dr Reddy's under the brand name Briviact.

Strides Shasun Limited

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

INDIA India

Post An Enquiry

Virtual Booth

BIO Digital 2021

Participation Not Confirmed

Update your events

Strides Pharma Science Arm Gets American Drug Regulator's Nod for Pain Relieving Drug

Lead Product(s): Ibuprofen

Therapeutic Area: Neurology Product Name: Undisclosed

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable February 24, 2021

Details:

Strides Pharma's Ibuprofen is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Children's Motrin Oral Suspension, 100 mg/mL, of Johnson & Johnson Consumer Inc.